...
首页> 外文期刊>Journal of Materials Science >One-step fabrication of bicompartmental microparticles as a dual drug delivery system for Parkinson's disease management
【24h】

One-step fabrication of bicompartmental microparticles as a dual drug delivery system for Parkinson's disease management

机译:双层组织微粒的一步制造作为帕金森病管理的双药物递送系统

获取原文
获取原文并翻译 | 示例
           

摘要

Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily affecting elderly patients. In order to efficiently manage the symptoms of the disease, controlled and continuous supply of PD drugs [levodopa (LD) and carbidopa (CD)] would be highly beneficial. Currently available commercial tablets are not sufficiently capable of releasing PD drugs in a sustainable fashion. Hence, the purpose of this study was to engineer a carrier system to deliver more than one therapeutic to the target site with independent, sustainable release kinetics. To achieve that, we have designed and developed a set of disk-shaped microparticles composed of two distinct compartments, the first containing a relatively hydrophilic amorphous polymer, poly(lactide-co-glycolide) and the second composed entirely of hydrophobic semicrystalline polylactide. These bicompartmental microparticles with narrow particle size distribution (coefficient of variance 6%) were fabricated by electrohydrodynamic co-jetting technique and characterized by optical microscopy, confocal laser scanning microscopy, SEM, DSC and Raman microscopy. The feasibility of the bicompartmentalized microparticles was confirmed by localizing two different hydrophilic PD drugs (LD and CD) in two different compartments with 4:1 ratio similar to commercially available tablets. This one-step particle fabrication method generated bicompartmental particles with high drug encapsulation efficiency (LD: 97% and CD: 68%). The resulting dual drug-loaded disk-shaped microparticles demonstrated simultaneous release of two independent PD drugs with similar release pattern (80% release of both drugs within 5h). These compartmentalized microparticles can potentially act as dual drug delivery system to enable controlled, sustained release of a wide range of water soluble drugs including PD drugs.
机译:帕金森病(PD)是一种主要影响老年患者的进步神经退行性疾病。为了有效地管理疾病的症状,Pd药物的控制和连续供应[Levodopa(LD)和Carbidopa(CD)]将是非常有益的。目前可用的商业平板电脑不能充分能够以可持续的方式释放PD药物。因此,本研究的目的是工程师系统,以通过独立的可持续释放动力学向目标部位提供多于一个治疗性。为此,我们已经设计和开发了一组由两个不同隔室组成的一组盘形微粒,首先含有相对亲水的无定形聚合物,聚(丙交酯 - 共乙酰胺)和完全由疏水的半晶聚氯酸酯组成的第二组成。这些具有窄粒度分布(6%系数6%)的双分量分散微粒由电学剧共射流技​​术制造,并通过光学显微镜,共聚焦激光扫描显微镜,SEM,DSC和拉曼显微镜进行了特征。通过将两种不同的亲水Pd药物(LD和Cd)定位在两个不同的隔室中,以与市售片剂相似的不同隔室,确认双组分化微粒的可行性。这种一步颗粒制造方法产生具有高药物包封效率的双组分颗粒(LD:& 97%和Cd:& 68%)。得到的双药物装载的盘状微粒和在5h内以类似的释放图案(& 80%释放两种药物)同时释放两个独立的Pd药物。这些隔间化的微粒可以充当双药物递送系统,以实现各种水溶性药物的控制,持续释放,包括Pd药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号